PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19958732-6	2009	The lack of patch-test reactivity to the analogous nonhydroxylated fatty acids, stearic acid (C18:0), and oleic acid (C18:1) indicates that 12-hydroxylation was required for allergenicity in this patient.	Oleic Acid	106-116	Bardet-Biedl syndrome 9	Homo sapiens	118-121	
16291625-0	2005	Dilution rate and pH effects on the conversion of oleic acid to trans C18:1 positional isomers in continuous culture.	Oleic Acid	50-60	Bardet-Biedl syndrome 9	Homo sapiens	70-73	
18469237-2	2008	Animal studies suggest that lauric acid (C12) may have more potent suppressive effects on energy intake than does oleic acid (C18).	Oleic Acid	114-124	Bardet-Biedl syndrome 9	Homo sapiens	126-129	
16291625-11	2005	The results of this study confirm that ruminal microorganisms are capable of converting oleic acid to a wide variety of trans-C18:1 positional isomers when ruminal conditions are favorable (such as the pH 6.5 and 0.10/h dilution rate treatment).	Oleic Acid	88-98	Bardet-Biedl syndrome 9	Homo sapiens	126-129	
16291625-12	2005	However, at low pH and dilution rate, the conversion of oleic acid to trans-C18:1 still occurs, but positional isomers produced are restricted to double bond positions from C6 to C10.	Oleic Acid	56-66	Bardet-Biedl syndrome 9	Homo sapiens	76-79	
11471698-1	2001	Oleic acid, an 18 carbon acid with one double bond (C18:1) was degraded anaerobically to palmitic (C16:0) and myristic (C14:0) acid by-products at 21 C by a culture unacclimated to long-chain fatty acids.	Oleic Acid	0-10	Bardet-Biedl syndrome 9	Homo sapiens	52-55	
16084671-4	2005	The increase is even more striking when measured as a ratio of stearic acid to the unsaturated C18 fatty acids (oleic acid and linoleic acid).	Oleic Acid	112-122	Bardet-Biedl syndrome 9	Homo sapiens	95-98	
8185196-0	1994	Intraduodenal acid augments oleic acid (C18)-induced cholecystokinin release.	Oleic Acid	28-38	Bardet-Biedl syndrome 9	Homo sapiens	40-43	
29996652-0	2018	Alginate-C18 Conjugate Nanoparticles Loaded in Tripolyphosphate-Cross-Linked Chitosan-Oleic Acid Conjugate-Coated Calcium Alginate Beads as Oral Insulin Carrier.	Oleic Acid	86-96	Bardet-Biedl syndrome 9	Homo sapiens	9-12	
1901065-2	1991	Arachidonic acid and oleic acid stimulated dose-dependent formation of lipid bodies over 0.5-1 h. Other C20 and C18 fatty acids were less active and demonstrated rank orders as follows: cis-unsaturated fatty acids were much more active than trans-fatty acids, and activity diminished with decreasing numbers of double bonds.	Oleic Acid	21-31	Bardet-Biedl syndrome 9	Homo sapiens	112-115	
35216678-4	2022	Palmitoleic acid and oleic acid, two common C16 and C18 fatty acids in blood, promote ACSL4-dependent tumor ferroptosis induced by IFNgamma plus AA.	Oleic Acid	21-31	Bardet-Biedl syndrome 9	Homo sapiens	52-55	
3588506-7	1987	The proportion of lower chain (less than C16) FFA decreased and the proportion of C16 and C18 FFA, in particular oleic acid, increased.	Oleic Acid	113-123	Bardet-Biedl syndrome 9	Homo sapiens	90-93	
27194929-3	2016	The results showed that concentrations of the fatty acids with oleic acid (C18:1n9c) and linoleic acid (C18:2n6c), triglycerides with C52 and C54, and cholesterol detected are proportional to the adulteration ratios remarkably.	Oleic Acid	63-73	Bardet-Biedl syndrome 9	Homo sapiens	75-78	
27194929-4	2016	Oleic acid (C18:1n9c), linoleic acid (C18:2n6c), C52, and C54 were lower in pure milk fat than in adulterated mixtures.	Oleic Acid	0-10	Bardet-Biedl syndrome 9	Homo sapiens	12-15	
27194929-6	2016	Thus, we suggest that oleic acid (C18:1n9c), linoleic acid (C18:2n6c), C52, C54, and cholesterol are suitable indicators and can be used as biomarkers to rapidly detect adulterated milk fat by gas chromatography.	Oleic Acid	22-32	Bardet-Biedl syndrome 9	Homo sapiens	34-37